Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2650-2664
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2650
Table 3 Univariate and multivariate analyses of predictive factors for clinically relevant pancreatic fistula in the study group (n = 189)
FactorUnivariate analysis
Multivariate analysis
OR95%CIP-valueOR95%CIP-value
Patient characteristics
Age (≥ 65 yr/< 65 yr)1.070.52-2.210.848
Sex (male/female)0.580.27-1.140.107
BMI (≥ 24/< 24 kg/m2)0.990.44-2.220.983
Diabetes mellitus (yes/no)0.730.26-2.040.546
Preoperative status
Location of tumor (pancreas/non-pancreas)0.660.32-1.350.256
Preoperative STB (≥ 22 μmol/L vs < 22 μmol/L)1.070.50-2.300.857
Preoperative pre-albumin (≥ 170 mg/L vs < 170 mg/L)0.840.38-1.880.672
Preoperative serum albumin (≥ 35 g/L vs < 35 g/L)0.190.09-0.40< 0.0010.920.85-0.990.032
Preoperative serum globulin (≥ 22 g/L vs < 22 g/L)2.590.58-11.650.201
Preoperative hemoglobin (≥ 110 g/L vs < 110 g/L)0.610.27-1.400.241
Preoperative WBC (≥ 3.5 × 109/L vs < 3.5 × 109/L)0.750.14-3.850.725
Preoperative PLT (≥ 150 × 109/L vs < 150 × 109/L)1.080.74-3.410.898
Intraoperative status
Pancreatic texture (hard/soft)0.050.02-0.12< 0.0010.250.10-0.640.004
Surgery (PD/PPPD)1.040.51-2.120.914
Pathologic type (benign/malignant)2.420.67-8.740.166
Main pancreatic duct diameter (≥ 3 mm vs < 3 mm)0.260.12-0.54< 0.0010.500.27-0.930.029
Pancreaticojejunostomy anastomosis (duct-to-mucosa/dunking method)0.580.25-1.340.202
Pancreatic duct stent (yes/no)1.710.62-4.730.301
Vascular invasion (yes/no)0.900.34-2.380.834
Operative time (≥ 300 min vs < 300 min)0.740.36-1.650.466
Estimated blood loss (≥ 500 mL vs < 500 mL)3.631.65-7.980.0011.0021.001-1.0030.006
Postoperative status
Serum albumin POD 1 (≥ 35 g/L vs < 35 g/L)0.740.34-1.650.466
Serum globulin POD 1 (≥ 22 g/L vs < 22 g/L)0.930.46-1.910.851
Hemoglobin POD 1 (≥ 110 g/L vs < 110 g/L)2.070.96-4.460.062